Crude oil futures surged on Monday due to disruptions in Russian refining capacity caused by Ukrainian drone strikes and Moscow's decision to cut output to comply with OPEC+ targets. The West Texas Intermediate (WTI) contract for May settled at $81.95 a barrel, up $1.32, while the Brent contract for May settled at $86.57 a barrel, also up $1.32. Russia instructed...
All eyes on Microsoft and Pfizer
2022-12-16 • Updated
Microsoft
Most analysts foresee that the software giant has to exceed market forecasts this time. And if it really does, Microsoft will skyrocket. The Wall Street consensus is for revenue of $35.7 billion with profits of $1.54 a share. Last time the company revealed revenue of $38 billion with profits of $1.46, beating estimates of $36.4 billion and $1.38, relatively. Microsoft has managed not only to withstand the devastating coronavirus, but also to outperform! Its’ different products such as Azure, Office365, PC – all benefit from the stay-at-home regime as lots of companies have been forced to work remotely. Elsewhere, the soon release of the new Xbox added optimism. No doubt that this time the results will be better than expected. Stifel bank ungraded its price target to $245.00. Get ready to use this great opportunity on October 27 at 23:30 MT time!
Microsoft is currently at the 50.0% Fibonacci retracement level. It’s great that there is more room for the stock to rise firstly to the 78.6% Fibonacci level of $225.00 and then to $233.00. Moreover, it has strong supports of the 50-day moving average of $212.00 just underneath, that it’s unlikely to cross. Awesome chance to gain some profit!
Pfizer
If it’s all clear for Microsoft, Pfizer’s position is not so strong. Pfizer is working in a collaboration with a young, but highly-potential company BioNTech. Their vaccine candidate is one of the few frontrunners in the race nowadays. As you may remember, Johnson & Johnson and AstraZeneca have already left the competition because of the patients’ negative reactions. So, who knows, maybe Pfizer will save the world from the virus. If they succeed, they will receive $1.95 billion from the US government to supply 100 million doses. Of course, the company depends not only on the success of the vaccine, but it also has many other products. Notably, it’s one of the deepest pipelines in the biopharmaceutical industry. Follow the earnings report on October 27 at 16:00 MT time and catch the market movement!
Pfizer is trading inside of the triangle pattern. It has approached the intersection of the trendlines, so the earnings report may become the decisive moment for the stock. If earnings are better than expected, Pfizer may jump to $39.00 and then to $40.50. Otherwise, the move below the 50-day moving average of $37.00 will drive the price to the 200-day MA at $36.25. Follow the releases and join the flow!
What should you do for trading stocks?
Trading stocks with FBS is easy. Follow the simple steps described below.
- First of all, be sure you’ve downloaded Metatrader 5. FBS allows you to trade stocks only through this software.
- Open the MT5 account in your personal area.
- Reveal all trading instruments by clicking “show all” at the “Market Watch” window.
- Start trading!
Similar
Bearish scenario: Sales below 80.00 with TP1: 79.60... Anticipated bullish scenario: Intraday purchases above 80.70 with TP: 81.50...
Brent oil is currently on a bullish trend, facing resistance near $84 and supported by the 200-day EMA. Breaking above this level could lead to a climb towards $90. Short-term support is observed around $80, backed by the 50-day EMA. As summer approaches and travel increases, crude oil tends to benefit from seasonal patterns. Despite temporary setbacks, buying...
Latest news
Jerome H. Powell, the Federal Reserve chair, stated that the central bank can afford to be patient in deciding when to cut interest rates, citing easing inflation and stable economic growth. Powell emphasized the Fed's independence from political influences, particularly relevant as the election season nears. The Fed had raised interest rates to 5.3 ...
Hello again my friends, it’s time for another episode of “What to Trade,” this time, for the month of April. As usual, I present to you some of my most anticipated trade ideas for the month of April, according to my technical analysis style. I therefore encourage you to do your due diligence, as always, and manage your risks appropriately.
Bearish scenario: Sell below 1.0820 / 1.0841... Bullish scenario: Buy above 1.0827...